Eli Lilly Chief Scientific Officer explains Zepbound’s weight loss advantage

Dan Skovronsky, Eli Lilly Chief Scientific Officer, joins ‘Fast Money’ to talk Zepbound’s recent trial results and what it means for Eli Lilly’s future growth.